Navigation Links
BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
Date:1/10/2008

BIRMINGHAM, Ala., Jan. 10 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced Thomas J. Simon, M.D. has joined BioCryst as a consultant and interim Chief Medical Officer. Dr. Simon brings more than 20 years of expertise in global pharmaceutical development to his position at BioCryst.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030414/BIOCRYSTLOGO )

"We are very pleased to have Tom join BioCryst at this important time," said Jon P. Stonehouse, President and Chief Executive Officer of BioCryst. "Tom brings a sound knowledge of systematic, worldwide product development from his tenure at Merck & Co. where he was responsible for moving several key products from the clinical development-stage through to marketing approval. As our programs continue to move forward Tom's expertise in product development will be of immeasurable value."

The Company has undertaken a search to find a permanent successor to Dr. Simon.

Most recently, Dr. Simon held the position of Vice President, Clinical and Quantitative Sciences Administration at Merck & Co. with responsibility as Acting Head of Oncology Clinical Research. During his tenure with Merck & Co, Dr. Simon held various senior clinical positions including responsibility for resource allocation and shared services in Clinical and Quantitative Sciences and Vice President, Gastroenterology Clinical Research. Prior to joining Merck & Co., Dr. Simon held senior clinical positions at William H. Rorer, Inc. of Ft. Washington, Pennsylvania and also at Miles Pharmaceuticals of West Haven, Connecticut.

Dr. Simon received his B.S. and M.S. from Stanford Univers
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
2. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
3. BioCryst to Present at UBS 2007 Global Life Sciences Conference
4. Medpace Strengthens Presence in Central Europe
5. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
6. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
7. DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
8. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
9. Anavex strengthens Board of Directors
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...re/ -- The world,s first concept demonstration t...ugh alternative to replace a petrochemically produ...ber with renewable biomass, made their debut in Co...display at a lounge in the common departure area a...December 21, while the other tire will make appear...
(Date:12/2/2009)...ber 2 , - "Bolstering Bio...ge" , Coinciding with the International Y...public is hosting an international conference in L...logical resources in Africa. The,conference will b...ers,scientific experts, private companies, repres...
(Date:12/2/2009)... December 2 Gamida Cell announced ...al (animal study) safety and,efficacy of a gene th...,Cornell Medical College and Gamida Cell. The prod...such as Cooley,s Anemia. , Gamida Cell is... vivo,populations of stem/progenitor cells. The c...
(Date:12/2/2009)... /PRNewswire-Asia/ -- Simcere Pharmaceutical Group...ading pharmaceutical company,specializing in the d...d,generic and proprietary pharmaceuticals in China...included in China,s National Drug Reimbursement Li...of Human Resources and Social,Security on November...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
..., - European Operating Room Nurses Association...bal Healthcare Educational Program, Accepted,for A...e, the global leader in healthcare barrier,protect...r step in supporting,the global healthcare profess...n. , After receiving earlier confirmation of a...
...ven University of Technology (TU/e) have developed...tions. For the first time they used mechanical for... fundamental concepts in chemistry. This allowed t... force. This discovery paves the way to developing...he influence of mechanical tension. The results of...
...ro announced today that they have entered into a s...ry phase research efforts at Roche,s global resear...n the areas of discovery chemistry and biology, wh...timelines. This agreement is an expansion of an e... experience in partnering with external companies ...
Other Biology Technology:Ansell Healthcare Espresses Firm Commitment to Support Continued Education of Healthcare Professionals Worldwide 2Ansell Healthcare Espresses Firm Commitment to Support Continued Education of Healthcare Professionals Worldwide 3Ansell Healthcare Espresses Firm Commitment to Support Continued Education of Healthcare Professionals Worldwide 4A molecular ripcord for chemical reactions 2BioDuro and Roche Expand Strategic Collaboration to Provide Drug Discovery Services 2
(Date:12/2/2009)...keless tobacco product called moist snuff placed ...ta to urge the tobacco industry to change manufact...nogens. Their study is published online in ACS, mo...t reports that this category of tobacco products c...and cancer-causing substances. Called polycyclic a...
(Date:12/2/2009)...scylinders of carbon about a nanometer in diameter... such as ultrastrong fibers, electrical wires in m...or fuel cells. Thanks to a new development by rese... Technology (NIST) and five partners, you can add ...struction of an aggressive form of breast cancer. ...
(Date:12/1/2009)...ave two different feeding strategies. A large pro...that they are generalist predators feeding on othe...ome, however, are "herbivorous". This is not to s...their diets consist of plant-derived matter. For e...lants to attract ants, called extra-floral nectar;...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants 2Obituary 3A Professor James Boyer Brown 60654 1Obituary 3A Professor James Boyer Brown 60654 2Obituary 3A Professor James Boyer Brown 60654 3Obituary 3A Professor James Boyer Brown 60654 4Obituary 3A Professor James Boyer Brown 60654 5Gastroenterology hepatology societies release report evaluating fellowship training curriculum 60651 1Gastroenterology hepatology societies release report evaluating fellowship training curriculum 60651 2Gastroenterology hepatology societies release report evaluating fellowship training curriculum 60651 3Allied Worlds Eugene Raitt Elected 2010 Chairman of the Board for the Direct Marketing Association 60650 1Allied Worlds Eugene Raitt Elected 2010 Chairman of the Board for the Direct Marketing Association 60650 2Allied Worlds Eugene Raitt Elected 2010 Chairman of the Board for the Direct Marketing Association 60650 3
...of surface-drifting plankton algae are able to sig...e surface waters, which can affect the global carb...an Antarctic expedition which has just drawn to a ...d by the Alfred Wegener Institute, part of the Hel...l team of scientists will discuss the results obta...
...nary leader who implemented most of the first Mari...rializing Guangdong Province, has been awarded the.... He will use the Fellowship to expand and improve... extensive coastal areas from the serious threats ... , Mr. Meng is the first-ever Pew Fellow in Mari...
...stralia, Leader of the Antarctic Marine Ecosystems...ooperative Research Centre in Tasmania, has been a...ne Conservation to help prevent unsustainable expl...ate sophisticated ecosystem-based management plans...rn Ocean, and work with Antarctic scientists and a...
Other Biology News:Antarctic expedition provides new insights into the role of the Southern Ocean for global climate 2Antarctic expedition provides new insights into the role of the Southern Ocean for global climate 3Antarctic expedition provides new insights into the role of the Southern Ocean for global climate 42008 Pew Fellowship in Marine Conservation awarded to Fan Meng; first Chinese fellow 22008 Pew Fellowship in Marine Conservation awarded to Fan Meng; first Chinese fellow 3Dr. Andrew Constable awarded 2008 Pew Fellowship in marine conservation 2Dr. Andrew Constable awarded 2008 Pew Fellowship in marine conservation 3
... Mch3 Lyophilized solid. Highly active enzyme...etics, cleavage of target substrates, and inhibito... protein. One unit is defined as the amount of e...No. 235400 per hour at 37 C at saturated substrate...
... Mouse Antibody to Cytokeratin 5 / 6 Cytokeratin ...f cytokeratin expressed in basal, the intermediate...thelia as well as transitional epithelia, complex ...a. Cytokeratin 6 (56 kD) is also a high molecular ...
BCASMC (B350-05) from European Collection of Cell Cultures (ECACC)
Goat Anti-Human RECK (F-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: